According to the latest report by IMARC Group, titled “Therapeutic Beds Market Report by Product (Clinical Beds, Household Beds, Accessories), Application (Acute Care Beds, Critical Care Beds, Long-term Beds), End User (Hospital and Clinics, Reproductive Care Centers, and Others), and Region 2024-2032," the global therapeutic beds market size reached US$ 4.5 Billion in 2023. Therapeutic beds are specially designed beds used to improve the comfort and convenience of patients. They consist of several components, such as a frame, mattress, head and footboards, side rails, breaks, wheels, electronics, sensors, and control systems. They are widely used for post-surgery recovery, respiratory support, bariatric care, pain management, pressure relief, rehabilitation, childbirth, and maternity care. Therapeutic beds are designed to distribute weight evenly and reduce pressure on vulnerable body parts, which enhances comfort, prevents complications, promotes recovery, and improves sleep quality. They also aid in increasing patients’ safety, improving clinical efficiency, and preventing falls, accidents, and other injuries.
Global Therapeutic Beds Market Trends:
The significant growth in the healthcare industry across the globe is one of the key factors creating a positive outlook for the market. Therapeutic beds are widely used in hospitals, clinics, nursing homes, and long-term care facilities to improve comfort, prevent bedsores, enhance mobility, alleviate pain, and increase patient safety. Along with this, the rising prevalence of chronic diseases, such as cancer, diabetes, respiratory illnesses, and cardiovascular diseases (CVDs), which require long-term bed rest and hospitalization, is acting as another growth-inducing factor. Furthermore, the widespread product utilization owing to the increasing geriatric population to facilitate caregiving, improve mobility, reduce chronic pain, promote faster recovery, and minimize the risk of falls and serious injuries is providing an impetus to the market growth. Additionally, the introduction of smart beds that use sensors to monitor patient movement and position, as well as other vital signs, such as heart rate, blood pressure, and respiration, which, in turn, enhance safety and improve clinical outcomes, is positively influencing the market growth. Besides this, the incorporation of tilt functionality in therapeutic beds, which enables patients to adjust angles to improve blood circulation, reduce pressure points, and facilitate easier movement, is favoring the market growth. Moreover, the implementation of various government initiatives to improve healthcare infrastructure and provide access to high-quality medical care is propelling the market growth. Other factors, including rising demand for at-home healthcare services, increasing investment in the research and development (R&D) of advanced products, and the growing emphasis on patients’ safety and comfort, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 6.6 Billion by 2032, exhibiting a CAGR of 4.23% during 2024-2032.
Market Summary:
- On the basis of the product, the market has been divided into clinical beds (regular, ICU, pediatric, birthing, bariatric, low air loss, and other beds), household beds, and accessories.
- Based on the application, the market has been classified into acute care, critical care, and long-term beds.
- On the basis of end user, the market has been divided into hospitals and clinics, reproductive care centers, and others.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
- The competitive landscape of the industry has also been examined, with some of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.
Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Product, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800